Selected research
Industry Growth & Trends
Global Yeast Expression Vector Industry Growth and Trends Forecast to 2032
Market perspective
The global Yeast Expression Vector market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Yeast Expression Vector is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Yeast Expression Vector is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Yeast Expression Vector is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Yeast Expression Vector include Thermo Fisher Scientific, Inc. (US), Sigma-Aldrich Corporation (US), QIAGEN (Netherlands), Promega Corporation (US), New England Biolabs (US), Merck Millipore (US), GenScript USA Inc. (US), DNA2.0 (US) and Clontech Laboratories, Inc. (US), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Yeast Expression Vector market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Yeast Expression Vector market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Yeast Expression Vector market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Yeast Expression Vector.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Yeast Expression Vector market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Yeast Expression Vector Market by Company
Thermo Fisher Scientific, Inc. (US)
Sigma-Aldrich Corporation (US)
QIAGEN (Netherlands)
Promega Corporation (US)
New England Biolabs (US)
Merck Millipore (US)
GenScript USA Inc. (US)
DNA2.0 (US)
Clontech Laboratories, Inc. (US)
Bio-Rad Laboratories (US)
Agilent Technologies (US)
Yeast Expression Vector Segment by Type
Saccharomyces Cerevisiae Expression Vectors
Pichia Pastoris Expression Vectors
K. Lactis Expression Vectors
Others
Yeast Expression Vector Segment by Application
Industrial
Research
Therapeutic
Yeast Expression Vector Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Yeast Expression Vector market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Yeast Expression Vector and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Yeast Expression Vector.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Yeast Expression Vector manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Yeast Expression Vector in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Saccharomyces Cerevisiae Expression Vectors
- Pichia Pastoris Expression Vectors
- K. Lactis Expression Vectors
- Others
Applications
- Industrial
- Research
- Therapeutic
Companies covered
- Thermo Fisher Scientific, Inc. (US)
- Sigma-Aldrich Corporation (US)
- QIAGEN (Netherlands)
- Promega Corporation (US)
- New England Biolabs (US)
- Merck Millipore (US)
- GenScript USA Inc. (US)
- DNA2.0 (US)
- Clontech Laboratories, Inc. (US)
- Bio-Rad Laboratories (US)
- Agilent Technologies (US)
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Yeast Expression Vector Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Yeast Expression Vector Sales Estimates and Forecasts (2021-2032)
- 1.3 Yeast Expression Vector Market by Type
- 1.3.1 Saccharomyces Cerevisiae Expression Vectors
- 1.3.2 Pichia Pastoris Expression Vectors
- 1.3.3 K. Lactis Expression Vectors
- 1.3.4 Others
- 1.4 Global Yeast Expression Vector Market Size by Type
- 1.4.1 Global Yeast Expression Vector Market Size Overview by Type (2021-2032)
- 1.4.2 Global Yeast Expression Vector Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Yeast Expression Vector Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Yeast Expression Vector Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Yeast Expression Vector Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Yeast Expression Vector Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Yeast Expression Vector Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Yeast Expression Vector Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Yeast Expression Vector Industry Trends
- 2.2 Yeast Expression Vector Industry Drivers
- 2.3 Yeast Expression Vector Industry Opportunities and Challenges
- 2.4 Yeast Expression Vector Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Yeast Expression Vector Revenue (2021-2026)
- 3.2 Global Top Players by Yeast Expression Vector Sales (2021-2026)
- 3.3 Global Top Players by Yeast Expression Vector Price (2021-2026)
- 3.4 Global Yeast Expression Vector Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Yeast Expression Vector Major Company Production Sites & Headquarters
- 3.6 Global Yeast Expression Vector Company, Product Type & Application
- 3.7 Global Yeast Expression Vector Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Yeast Expression Vector Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Yeast Expression Vector Players Market Share by Revenue in 2025
- 3.8.3 2025 Yeast Expression Vector Tier 1, Tier 2, and Tier 3
4 Yeast Expression Vector Regional Status and Outlook
- 4.1 Global Yeast Expression Vector Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Yeast Expression Vector Historic Market Size by Region
- 4.2.1 Global Yeast Expression Vector Sales in Volume by Region (2021-2026)
- 4.2.2 Global Yeast Expression Vector Sales in Value by Region (2021-2026)
- 4.2.3 Global Yeast Expression Vector Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Yeast Expression Vector Forecasted Market Size by Region
- 4.3.1 Global Yeast Expression Vector Sales in Volume by Region (2027-2032)
- 4.3.2 Global Yeast Expression Vector Sales in Value by Region (2027-2032)
- 4.3.3 Global Yeast Expression Vector Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Yeast Expression Vector by Application
- 5.1 Yeast Expression Vector Market by Application
- 5.1.1 Industrial
- 5.1.2 Research
- 5.1.3 Therapeutic
- 5.2 Global Yeast Expression Vector Market Size by Application
- 5.2.1 Global Yeast Expression Vector Market Size Overview by Application (2021-2032)
- 5.2.2 Global Yeast Expression Vector Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Yeast Expression Vector Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Yeast Expression Vector Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Yeast Expression Vector Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Yeast Expression Vector Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Yeast Expression Vector Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Yeast Expression Vector Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Thermo Fisher Scientific, Inc. (US)
- 6.1.1 Thermo Fisher Scientific, Inc. (US) Company Information
- 6.1.2 Thermo Fisher Scientific, Inc. (US) Business Overview
- 6.1.3 Thermo Fisher Scientific, Inc. (US) Yeast Expression Vector Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Thermo Fisher Scientific, Inc. (US) Yeast Expression Vector Product Portfolio
- 6.1.5 Thermo Fisher Scientific, Inc. (US) Recent Developments
- 6.2 Sigma-Aldrich Corporation (US)
- 6.2.1 Sigma-Aldrich Corporation (US) Company Information
- 6.2.2 Sigma-Aldrich Corporation (US) Business Overview
- 6.2.3 Sigma-Aldrich Corporation (US) Yeast Expression Vector Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Sigma-Aldrich Corporation (US) Yeast Expression Vector Product Portfolio
- 6.2.5 Sigma-Aldrich Corporation (US) Recent Developments
- 6.3 QIAGEN (Netherlands)
- 6.3.1 QIAGEN (Netherlands) Company Information
- 6.3.2 QIAGEN (Netherlands) Business Overview
- 6.3.3 QIAGEN (Netherlands) Yeast Expression Vector Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 QIAGEN (Netherlands) Yeast Expression Vector Product Portfolio
- 6.3.5 QIAGEN (Netherlands) Recent Developments
- 6.4 Promega Corporation (US)
- 6.4.1 Promega Corporation (US) Company Information
- 6.4.2 Promega Corporation (US) Business Overview
- 6.4.3 Promega Corporation (US) Yeast Expression Vector Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Promega Corporation (US) Yeast Expression Vector Product Portfolio
- 6.4.5 Promega Corporation (US) Recent Developments
- 6.5 New England Biolabs (US)
- 6.5.1 New England Biolabs (US) Company Information
- 6.5.2 New England Biolabs (US) Business Overview
- 6.5.3 New England Biolabs (US) Yeast Expression Vector Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 New England Biolabs (US) Yeast Expression Vector Product Portfolio
- 6.5.5 New England Biolabs (US) Recent Developments
- 6.6 Merck Millipore (US)
- 6.6.1 Merck Millipore (US) Company Information
- 6.6.2 Merck Millipore (US) Business Overview
- 6.6.3 Merck Millipore (US) Yeast Expression Vector Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Merck Millipore (US) Yeast Expression Vector Product Portfolio
- 6.6.5 Merck Millipore (US) Recent Developments
- 6.7 GenScript USA Inc. (US)
- 6.7.1 GenScript USA Inc. (US) Company Information
- 6.7.2 GenScript USA Inc. (US) Business Overview
- 6.7.3 GenScript USA Inc. (US) Yeast Expression Vector Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 GenScript USA Inc. (US) Yeast Expression Vector Product Portfolio
- 6.7.5 GenScript USA Inc. (US) Recent Developments
- 6.8 DNA2.0 (US)
- 6.8.1 DNA2.0 (US) Company Information
- 6.8.2 DNA2.0 (US) Business Overview
- 6.8.3 DNA2.0 (US) Yeast Expression Vector Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 DNA2.0 (US) Yeast Expression Vector Product Portfolio
- 6.8.5 DNA2.0 (US) Recent Developments
- 6.9 Clontech Laboratories, Inc. (US)
- 6.9.1 Clontech Laboratories, Inc. (US) Company Information
- 6.9.2 Clontech Laboratories, Inc. (US) Business Overview
- 6.9.3 Clontech Laboratories, Inc. (US) Yeast Expression Vector Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Clontech Laboratories, Inc. (US) Yeast Expression Vector Product Portfolio
- 6.9.5 Clontech Laboratories, Inc. (US) Recent Developments
- 6.10 Bio-Rad Laboratories (US)
- 6.10.1 Bio-Rad Laboratories (US) Company Information
- 6.10.2 Bio-Rad Laboratories (US) Business Overview
- 6.10.3 Bio-Rad Laboratories (US) Yeast Expression Vector Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Bio-Rad Laboratories (US) Yeast Expression Vector Product Portfolio
- 6.10.5 Bio-Rad Laboratories (US) Recent Developments
- 6.11 Agilent Technologies (US)
- 6.11.1 Agilent Technologies (US) Company Information
- 6.11.2 Agilent Technologies (US) Business Overview
- 6.11.3 Agilent Technologies (US) Yeast Expression Vector Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Agilent Technologies (US) Yeast Expression Vector Product Portfolio
- 6.11.5 Agilent Technologies (US) Recent Developments
7 North America by Country
- 7.1 North America Yeast Expression Vector Sales by Country
- 7.1.1 North America Yeast Expression Vector Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Yeast Expression Vector Sales by Country (2021-2026)
- 7.1.3 North America Yeast Expression Vector Sales Forecast by Country (2027-2032)
- 7.2 North America Yeast Expression Vector Market Size by Country
- 7.2.1 North America Yeast Expression Vector Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Yeast Expression Vector Market Size by Country (2021-2026)
- 7.2.3 North America Yeast Expression Vector Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Yeast Expression Vector Sales by Country
- 8.1.1 Europe Yeast Expression Vector Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Yeast Expression Vector Sales by Country (2021-2026)
- 8.1.3 Europe Yeast Expression Vector Sales Forecast by Country (2027-2032)
- 8.2 Europe Yeast Expression Vector Market Size by Country
- 8.2.1 Europe Yeast Expression Vector Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Yeast Expression Vector Market Size by Country (2021-2026)
- 8.2.3 Europe Yeast Expression Vector Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Yeast Expression Vector Sales by Country
- 9.1.1 Asia-Pacific Yeast Expression Vector Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Yeast Expression Vector Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Yeast Expression Vector Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Yeast Expression Vector Market Size by Country
- 9.2.1 Asia-Pacific Yeast Expression Vector Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Yeast Expression Vector Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Yeast Expression Vector Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Yeast Expression Vector Sales by Country
- 10.1.1 South America Yeast Expression Vector Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Yeast Expression Vector Sales by Country (2021-2026)
- 10.1.3 South America Yeast Expression Vector Sales Forecast by Country (2027-2032)
- 10.2 South America Yeast Expression Vector Market Size by Country
- 10.2.1 South America Yeast Expression Vector Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Yeast Expression Vector Market Size by Country (2021-2026)
- 10.2.3 South America Yeast Expression Vector Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Yeast Expression Vector Sales by Country
- 11.1.1 Middle East and Africa Yeast Expression Vector Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Yeast Expression Vector Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Yeast Expression Vector Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Yeast Expression Vector Market Size by Country
- 11.2.1 Middle East and Africa Yeast Expression Vector Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Yeast Expression Vector Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Yeast Expression Vector Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Yeast Expression Vector Value Chain Analysis
- 12.1.1 Yeast Expression Vector Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Yeast Expression Vector Production Mode & Process
- 12.2 Yeast Expression Vector Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Yeast Expression Vector Distributors
- 12.2.3 Yeast Expression Vector Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst